Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
MARKETS

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & Drugs

| BSE 1942.95 22.00 (1.15%) | |

BSE Live

Nov 27, 16:01
1942.95 22.00 (1.15%)
Volume
AVERAGE VOLUME
5-Day
27,193
10-Day
35,980
30-Day
41,055
34,542

  • Prev. Close

    1920.95

  • Open Price

    1934.95

  • Bid Price (Qty.)

    1930.00 (2)

  • Offer Price (Qty.)

    1949.00 (10)

NSE Live

Nov 27, 15:58
1944.00 22.70 (1.18%)
Volume
AVERAGE VOLUME
5-Day
1,099,533
10-Day
1,742,811
30-Day
1,043,587
1,272,760

  • Prev. Close

    1921.30

  • Open Price

    1924.70

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1944.00 (2539)

Financials

Cash Flow of Glenmark Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 1,534.64 1,818.18 1,218.83 2,552.90 1,746.53  
Net CashFlow From Operating Activities 1,579.12 2,489.58 1,123.72 877.72 354.75  
Net Cash Used In Investing Activities -1,607.38 -2,255.61 -1,137.12 -2,580.29 -1,545.60  
Net Cash Used From Financing Activities -139.42 -155.11 -61.58 1,879.38 1,222.55  
Foreign Exchange Gains / Losses -0.02 0.08 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.15 -0.17 0.51  
Net Inc/Dec In Cash And Cash Equivalents -167.71 78.95 -74.84 176.64 32.23  
Cash And Cash Equivalents Begin of Year 255.00 176.05 250.88 74.24 42.02  
Cash And Cash Equivalents End Of Year 87.29 255.00 176.05 250.88 74.24  
Source : Dion Global Solutions Limited

Results of Glenmark

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347